Kymera Therapeutics

Kymera Therapeutics describes itself as a clinical-stage biotechnology company working to reinvent the treatment of human disease through innovative, highly differentiated medicines. It is committed to advancing novel technologies such as targeted protein degradation to address previously undrugged disease-causing proteins, and states that it has built a discovery engine capable of advancing at least one new program into clinical testing every year. Its leadership team includes Founder, President & CEO Nello Mainolfi, PhD.

Kymera Therapeutics is a clinical-stage biotechnology company that states it is working to reinvent the treatment of human disease through innovative, highly differentiated medicines. It is committed to advancing novel technologies such as targeted protein degradation to address previously undrugged disease-causing proteins. The company states that since its founding it has built a discovery engine capable of identifying new drug candidates at an accelerated pace and advancing at least one new program into clinical testing every year. Its leadership includes Founder, President & CEO Nello Mainolfi, PhD, and Co-Founder Bruce Booth, DPhil, who serves as a board member.

Clinical-stage biotechnology company focused on targeted protein degradation and first-in-class therapeutics.

1. 1Revolutionary Medicines Catalyzed by Protein Degradation | Kymera Therapeuticskymeratx.com
2. 2Our Company | Kymera Therapeuticskymeratx.com
3. 3Leadership | Kymera Therapeuticskymeratx.com
4. 4Kymera Therapeuticswikidata.org
5. 5A-Alpha Bio Partners with Kymera Therapeutics to Discover Novel Interactions for Molecular Glue Discoveryprweb.com
6. 6Kymera Therapeutics Appoints Juliet Williams, PhD, as Senior Vice President, Head of Biologybiospace.com